Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
Top Cited Papers
- 1 September 2002
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 2 (3) , 183-192
- https://doi.org/10.1016/s1535-6108(02)00127-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Direct addition of BimL to mitochondria does not lead to cytochrome c releaseFEBS Letters, 2002
- Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-XLOncogene, 2002
- The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2Cell Death & Differentiation, 2001
- BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and BakGenes & Development, 2001
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced ApoptosisScience, 2000
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Movement of Bax from the Cytosol to Mitochondria during ApoptosisThe Journal of cell biology, 1997
- Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of ApoptosisScience, 1997
- Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell deathCell, 1995